CGH2466, a combined adenosine receptor antagonist, p38 mitogen-activated protein kinase and phosphodiesterase type 4 inhibitor with potent in vitro and in vivo anti-inflammatory activities. [electronic resource]
- British journal of pharmacology Apr 2005
- 1002-10 p. digital